PROM1 and lung carcinoma: Intending to evaluate this capability on lung cancer cells, we first assessed the viability of A549, wLLC, CD133+ LLC, CD133− LLC, fibroblasts, and Thp1 human monocytes after exposure to different doses of 4Mu (Fig. 3A).